The TGF-β inhibitor SD208 has been shown to reduce the CAF-induced expression of stemness markers and simultaneously induced the expression of differentiation markers in CAF-cocultivated CRC cells (65). The gene discussed is TGFB1; the disease is colorectal carcinoma.